Live births after management of severe OHSS by GnRH antagonist administration in the luteal phase TG Lainas, IA Sfontouris, IZ Zorzovilis, GK Petsas, GT Lainas, E Alexopoulou, EM Kolibianakis Reproductive BioMedicine Online Volume 19, Issue 6, Pages 789-795 (December 2009) DOI: 10.1016/j.rbmo.2009.09.021 Copyright © 2009 Reproductive Healthcare Ltd. Terms and Conditions
Figure 1 Concentrations of (a) oestradiol, (b) progesterone, (c) right and (d) left ovarian volume, (e) haematocrit, (f) white blood cells, (g) urea and (h) creatinine during the monitoring period. Gonadotrophin-releasing hormone antagonist administration was initiated on day 6 and terminated on day 10. Human chorionic gonadotrophin (HCG) administration was on day 2 and oocyte retrieval was performed on day 0. Estimation of β-HCG was performed on days 14 and 16. Reproductive BioMedicine Online 2009 19, 789-795DOI: (10.1016/j.rbmo.2009.09.021) Copyright © 2009 Reproductive Healthcare Ltd. Terms and Conditions